• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Lilly, Vir, GSK Partner to Evaluate COVID Combo Therapies

    Novartis Invests in Credence MedSystems

    Ajinomoto Bio-Pharma, Humanigen Expand Manufacturing Agreement

    Almac Expands Global Biologics Testing Services

    GRAM Makes Major Investment in Additional Advanced Equipment
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Ajinomoto Bio-Pharma, Humanigen Expand Manufacturing Agreement

    GRAM Makes Major Investment in Additional Advanced Equipment

    Aphena’s $21M Cookeville Expansion Nears Completion

    PromoCell Receives EXCiPACT Certification

    Civica to Build an Essential Medicines Manufacturing Facility in Virginia
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Novartis Invests in Credence MedSystems

    Aphena’s $21M Cookeville Expansion Nears Completion

    Civica to Build an Essential Medicines Manufacturing Facility in Virginia

    WDSrx Expands Warehouse Network

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Lilly, Vir, GSK Partner to Evaluate COVID Combo Therapies

    Almac Expands Global Biologics Testing Services

    The State of Clinical Trial Technology

    Adare Pharma Solutions Opens New Small-Scale Lab

    The Future of Clinical Trials Series: Part II
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    Emergent BioSolutions

    Adare Pharma Solutions

    Cytovance Biologics

    Aphena Pharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Syngene

    Aphena Pharma Solutions

    PCI Pharma Services

    Cytovance Biologics

    Almac Group
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    CiToxLAB Expands Inhalation Test Capabilities

    Adds capabilities in North America and Europe

    Related CONTENT
    • CPhI North America Event Info
    • KBI Biopharma Invests $30M in Facility Upgrades
    • CROS NT Expands Medidata Pact
    • Hitachi Chemical Acquires Remaining Stake in PCT
    • Aptar Pharma’s Electronic Lockout Device Approved by EMA
    03.08.12
    CiToxLAB has increased its inhalation test capabilities in North America and Europe. CiToxLAB-North America has opened a new rodent and non-rodent inhalation facility, adding the ability to evaluate pharmaceuticals, biological compounds and inhalation devices.
     
    The studies conducted at the facility will use seven rodent suites and five non-rodent suites, with capabilities to perform studies by the inhalation route in all species. In CiToxLAB-North America, the Canadian team has more than 25 years of cumulative experience in exposure of multiple animal species to single or repeated nose-only and oronasal exposure routes in liquids, powders, vapors and metered dose inhalers.
     
    In Europe, CiToxLAB-Hungary is equipped with three rodent suites and one non-rodent suite, doubling its rodent capacity. The new area will be fully operational by the end of 2Q12. The Hungary team of scientists and technicians has a combined 80 years of experience.
     
    “We are now able to offer this type of inhalation testing on both sides of the Atlantic and at favorable prices when compared to our competitors,” said Jean-François Le Bigot, chief executive officer of CiToxLAB. “The services offered via the inhalation route in the Hungarian and North American facilities are complementary with the expertise provided by the other facilities, including CiToxLAB-France and CiToxLAB-Scantox in Denmark, which directly highlights the benefits of our acquisition of LAB Research last year.”
    Related Searches
    • Testing
    • Preclinical Outsourcing
    Suggested For You
    CPhI North America Event Info CPhI North America Event Info
    KBI Biopharma Invests $30M in Facility Upgrades KBI Biopharma Invests $30M in Facility Upgrades
    CROS NT Expands Medidata Pact CROS NT Expands Medidata Pact
    Hitachi Chemical Acquires Remaining Stake in PCT  Hitachi Chemical Acquires Remaining Stake in PCT
    Aptar Pharma’s Electronic Lockout Device Approved by EMA Aptar Pharma’s Electronic Lockout Device Approved by EMA
    Thermo Fisher Buys Patheon for $7.2B Thermo Fisher Buys Patheon for $7.2B
    Newsmakers: Elliott Berger Newsmakers: Elliott Berger
    CPHL North America Exhibitor List CPHL North America Exhibitor List
    PPD Expands Lab Services in Ireland PPD Expands Lab Services in Ireland
    What is Needed From a Next-Generation Inhalation Device? What is Needed From a Next-Generation Inhalation Device?
    CiToxLAB Appoints Toxicology/Ops Director CiToxLAB Appoints Toxicology/Ops Director
    Inhalation Drug Delivery ‐ Understanding Basic Steps Involved in pMDI Development Inhalation Drug Delivery ‐ Understanding Basic Steps Involved in pMDI Development
    CIT Acquires LAB Research CIT Acquires LAB Research

    Related Breaking News

    • Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
      X-Chem Acquires IntelliSyn and AviSyn

      X-Chem Acquires IntelliSyn and AviSyn

      Acquisitions allow the company to offer services for screening, hit validation and lead optimization on existing and new markets.
      Kristin Brooks 01.26.21

    • Breaking News | CRO News | Drug Discovery | Preclinical Outsourcing
      Charles River Labs Acquires Distributed Bio

      Charles River Labs Acquires Distributed Bio

      Establishes integrated, large molecule discovery platform.
      Contract Pharma Staff 01.04.21

    • Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News | Preclinical Outsourcing
      Ocugen Engages Kemwell Biopharma for cGMP Manufacture of OCU200

      Ocugen Engages Kemwell Biopharma for cGMP Manufacture of OCU200

      Paves the way towards getting OCU200 in the clinic by first half of 2022.
      Contract Pharma Staff 10.06.20


    • Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
      Evotec, Samsara BioCapital, and KCK Launch Autobahn Labs

      Evotec, Samsara BioCapital, and KCK Launch Autobahn Labs

      A novel early stage drug discovery incubator.
      Contract Pharma Staff 06.24.20

    • Analytical Services | Breaking News | CRO News | Drug Development | Industry News | Preclinical Outsourcing
      Frontage Establishes Center of Excellence

      Frontage Establishes Center of Excellence

      Quantitative whole-body autoradiography CoE will be located in Exton, PA and headed by Michael Potchobia.
      Contract Pharma Staff 06.02.20

    • CRO News | Preclinical Outsourcing
      Rho, TRI Partner on Risk-Based Quality Management

      Rho, TRI Partner on Risk-Based Quality Management

      Technology platform aims to optimize trial quality by improving data reliability, patient safety and operational efficiency
      01.14.20


    • Biologics, Proteins, Vaccines | CRO News | Drug Discovery | Preclinical Outsourcing
      Charles River to Acquire HemaCare Corp. for $380M

      Charles River to Acquire HemaCare Corp. for $380M

      Expands scientific capabilities for cell and gene therapies
      12.16.19

    • Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
      Charles River Provides Access to Cosmic Antibody Library

      Charles River Provides Access to Cosmic Antibody Library

      Expanded antibody library launched by Distributed Bio aims to expedite the drug discovery process
      12.12.19

    • Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
      BioIVT Acquires PPA Research Group

      BioIVT Acquires PPA Research Group

      Expands product portfolio to support immuno-oncology and cell therapy research
      10.18.19


    • Industry News | Preclinical Outsourcing
      Genesis Aquires NexusPharma

      Genesis Aquires NexusPharma

      Expands preclinical contract research portfolio and integrates unique xenograft models
      06.18.19

    • Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Preclinical Outsourcing | Process Development
      WuXi STA Forms Partnership with Beta Pharma

      WuXi STA Forms Partnership with Beta Pharma

      STA will accelerate process R&D and manufacturing of late phase and commercial targets
      03.21.19

    • Breaking News | Industry News | Laboratory Testing | Preclinical Outsourcing
      Envigo Launches PATHWAY

      Envigo Launches PATHWAY

      Designed to optimize non-clinical safety assessment programs
      03.12.19


    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
      Valitacell, Solentim Form Biologics Collaboration

      Valitacell, Solentim Form Biologics Collaboration

      Goal is to enable earlier identification of biological candidates
      02.22.19

    • Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | Preclinical Outsourcing
      Janssen, Morphic Ink Deal Worth up to $750M

      Janssen, Morphic Ink Deal Worth up to $750M

      Deal extends reach of Morphic discovery across all known human integrins
      02.22.19

    • Breaking News | Collaborations & Alliances | Industry News | Preclinical Outsourcing
      Alkermes, Clovis Form Cancer Research Collaboration

      Alkermes, Clovis Form Cancer Research Collaboration

      Together will explore combination cancer therapies
      02.20.19

    Trending
    • Integrated Continuous Manufacturing ICM
    • Humanigen, Emergent Enter Covid-19 Partnership
    • 500+ Sites Join Inato’s Industry Marketplace
    • Samsung Bioepis Opens New Headquarters
    • CDMO Northway Biotech Expands In U.S.
    Breaking News
    • Lilly, Vir, GSK Partner to Evaluate COVID Combo Therapies
    • Novartis Invests in Credence MedSystems
    • Ajinomoto Bio-Pharma, Humanigen Expand Manufacturing Agreement
    • Almac Expands Global Biologics Testing Services
    • GRAM Makes Major Investment in Additional Advanced Equipment
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

      View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    PepsiCo and Beyond Meat Partner to Develop Plant-Based Protein
    New Study on Sage Extract Formula Suggests Memory Enhancement
    Omega-3s Evidenced to Reduce Low-Grade Inflammation in Elderly Men
    Coatings World

    Latest Breaking News From Coatings World

    Mississippi Lime Company Announces New Director of Safety
    IFS Coatings Launches IFS Puroplaz PE20 Texture
    Keyland Polymer UV Powder, LLC Launches UVMax Defender
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Spectrum Solutions Collaborates with UCLA School of Dentistry
    Kwivik Therapeutics, EirMed Partner to Accelerate Product Commercialization
    Europe Marks its First Successful Remote Robotic-Assisted Coronary Angioplasty
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Lilly, Vir, GSK Partner to Evaluate COVID Combo Therapies
    Novartis Invests in Credence MedSystems
    Ajinomoto Bio-Pharma, Humanigen Expand Manufacturing Agreement
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Coty to Shut Down Manufacturing Site in Cologne, Germany
    L’Occitane Files for Bankruptcy in U.S.
    Bésame Cosmetics Collaborates with Disney on Mary Poppins Collection
    Happi

    Latest Breaking News From Happi

    HI Beach Installs Reef-friendly Sunscreen Dispenser
    RB Partners with Airbnb
    L'Occitane US Files for Bankruptcy
    Ink World

    Latest Breaking News From Ink World

    Epson Partner Creates Label Applicators for Pharmaceutical Products
    Smurfit Kappa Sets New Sustainability Targets with Better Planet 2050
    Georgia-Pacific Acquires 3rd HP PageWide Corrugated Press to Expand Hummingbird Digital Printing
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Arjobex acquires MDV Group
    Fix-A-Form eyes global expansion
    McCracken Label installs Fujifilm water-wash plate system
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Nice-Pak Receives EPA Approval for Disinfecting Wipes
    Rockline to Invest $18 Million in Arkansas
    Essity’s Sales Negatively Impacted by Covid-19 Pandemic
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ChoiceSpine's Tiger Shark Cervical Spacer Earns Additional 510(k)
    FDA Green Lights Inspired Spine's Trident SI Joint Screw System
    FDA Clears Method to Extract Bone Measurements From X-Rays
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Osram Sees Jump in Profits in Preliminary 2020 Report
    LG Display Reports 4Q 2020 Results
    Xerox Releases 4Q, Full Year Results

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login